Extracellular matrix-degrading STING nanoagonists for mild NIR-II photothermal-augmented chemodynamic-immunotherapy

Regulation of stimulator of interferon genes (STING) pathway using agonists can boost antitumor immunity for cancer treatment, while the rapid plasma clearance, limited membrane permeability, and inefficient cytosolic transport of STING agonists greatly compromise their therapeutic efficacy. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Meixiao, Yu, Xiangrong, Zhao, Wei, Peng, Yongjun, Peng, Shaojun, Li, Jingchao, Lu, Ligong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740364/
https://www.ncbi.nlm.nih.gov/pubmed/34991618
http://dx.doi.org/10.1186/s12951-021-01226-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740364/
https://www.ncbi.nlm.nih.gov/pubmed/34991618
http://dx.doi.org/10.1186/s12951-021-01226-3

Ejemplares similares